During Tuesday’s trading session, shares of a global biopharmaceutical company engaged in the manufacturing of biotechnology products and research services are in focus, after the company launched a Qualified Institutions Placement (QIP) to raise up to Rs. 4,500...
Shares of a leading pharmaceutical company rose nearly 2 percent in today’s trading session after the firm announced it had secured regulatory approval for its new diabetes drug. The development marks a significant milestone in the company’s efforts to expand its...
Pharma stock that offers generic formulations and API products, including anti-diabetics, immunosuppressants, and many more in focus after receiving US FDA’s approval for Key Cancer drugs. Price Movement With a market capitalization of ₹38,251 Crores the shares of...
This leading pharma company stock is in focus after its drug, YESINTEK has been approved by the European Commission for marketing in the European Union region. Share Price Movement With a market capitalization of Rs. 40,322 Crore, the stock of Biocon opened at Rs....
One of the pharmaceutical stocks engaged in the manufacturing of biotechnology products and research services. The stock is in focus after receiving approval from China’s National Medical Products Administration (NMPA) for Tacrolimus capsules Stock Price...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
